SANN — Santhera Pharmaceuticals Holding AG Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣180.62m
- CH₣190.50m
- CH₣103.41m
- 17
- 77
- 92
- 70
Annual cashflow statement for Santhera Pharmaceuticals Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18.4 | -67.5 | -54.7 | -70.6 | 54.8 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 7.32 | 2.34 | -19.4 | 4.18 | -19.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 8.9 | 14.5 | 33 | 26.7 | 8.64 |
| Change in Other Assets | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.6 | -43.5 | -37.4 | -29.8 | 47.3 |
| Capital Expenditures | -0.229 | -0.034 | -0.015 | -3.96 | -23.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 3.02 | 1.6 | 0.084 | 0.024 | 5.7 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2.79 | 1.56 | 0.069 | -3.93 | -18 |
| Financing Cash Flow Items | -1.94 | -0.317 | -5.83 | -0.389 | 2.38 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.13 | 23.1 | 46 | 14 | -0.171 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.39 | -18.9 | 8.8 | -19.9 | 29 |